In 2014 vaardigde de American College of Cardiology
en de American Heart Association nieuwe richtlijnen uit
voor statinetherapie. Zelfs gezonde personen met een laag
hartrisicoprofiel zouden dan statines moeten nemen. In de UK komt
een kwart van de bevolking tussen 30 en 85 jaar daarvoor in
aanmerking.1 Vier experts hebben felle kritiek
uitgeoefend op de nieuwe richtlijnen in een opiniestuk voor de
British Medical Journal.2
Beste bezoeker, u heeft geen toegang.
Enkel (web)abonnees hebben toegang tot tijdschriftartikelen. Het webabonnement is nog in de maak.
U kunt zich wel alvast (gratis) registreren en tal van andere webartikelen raadplegen!
Auteur
Verschenen in
Referenties
Goldacre B, Smeeth L. Mass treatment with statins. BMJ. 2014 Jul 22;349:g4745
Abramson JD, Rosenberg HG, Jewell N, Wright JM. Should people at low risk of cardiovascular disease take a statin? BMJ. 2013 Oct 22;347:f6123
Golomb BA, Evans MA, Dimsdale JE, White HL. Effects of statins on energy and fatigue with exertion: results from a randomized controlled trial. Arch Intern Med. 2012 Aug 13;172(15):1180-2
Mikus CR, Boyle LJ, Borengasser SJ, Oberlin DJ et al. Simvastatin impairs exercise training adaptations. J Am Coll Cardiol. 2013 Aug 20;62(8):709-14
Diamond DM, Ravnskov U. How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease. Expert Rev Clin Pharmacol. 2015 Mar;8(2):201-10
Diamond DM, Ravnskov U. How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease. Expert Rev Clin Pharmacol. 2015 Mar;8(2):201-10
Lytras T, Nikolopoulos G, Bonovas S. Statins and the risk of colorectal cancer: an updated systematic review and meta-analysis of 40 studies. World J Gastroenterol. 2014 Feb 21;20(7):1858-70
Singh PP, Singh S. Statins are associated with reduced risk of gastric cancer: a systematic review and meta-analysis. Ann Oncol. 2013 Jul;24(7):1721-30
Kantor ED, Lipworth L, Fowke JH et al. Statin use and risk of prostate cancer: Results from the Southern Community Cohort Study. Prostate. 2015 May 27. doi: 10.1002/pros.23019
Pradelli D, Soranna D, Zambon A et al. Statins use and the risk of all and subtype hematological malignancies: a meta-analysis of observational studies. Cancer Med. 2015 May;4(5):770-80
Undela K, Srikanth V, Bansal D. Statin use and risk of breast cancer: a meta-analysis of observational studies. Breast Cancer Res Treat. 2012 Aug;135(1):261-9
Zhang XL, Liu M, Qian J et al. Statin use and risk of kidney cancer: a meta-analysis of observational studies and randomized trials. Br J Clin Pharmacol. 2014 Mar;77(3):458-65
Bonovas S, Nikolopoulos G, Filioussi K et al. Can statin therapy reduce the risk of melanoma? A meta-analysis of randomized controlled trials. Eur J Epidemiol. 2010;25(1):29-35
Zhong S, Zhang X, Chen L et al. Statin use and mortality in cancer patients: Systematic review and meta-analysis of observational studies. Cancer Treat Rev. 2015 Jun;41(6):554-67. doi: 10.1016/j.ctrv.2015.04.005
Zhang XL, Geng J, Zhang XP et al. Statin use and risk of bladder cancer: a meta-analysis. Cancer Causes Control. 2013 Apr;24(4):769-76
McDougall JA, Malone KE, Daling JR et al. Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age. Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1529-37
Ferdinand KC. Are cardiovascular benefits in statin lipid effects dependent on baseline lipid levels? Curr Atheroscler Rep. 2011 Feb;13(1):64-72
Abramson JD, Rosenberg HG, Jewell N, Wright JM. Should people at low risk of cardiovascular disease take a statin? BMJ. 2013 Oct 22;347:f6123
Goldacre B, Smeeth L. Mass treatment with statins. BMJ. 2014 Jul 22;349:g4745
